During the 8th edition of the Global Health Exhibition, hosted in Riyadh, specialized investment funds in the biotechnology sector were announced in the Kingdom of Saudi Arabia, marking a major step toward advancing the national biotechnology landscape and strengthening the country’s position as a global hub for life sciences innovation.
The announcements included:
- GOLDTRACK Ventures launched a biotechnology investment fund worth $250.7 million, aimed at accelerating the growth of biotech startups and supporting early-stage innovation.
- IB Ventures introduced a biotechnology investment fund valued at $46.7 million, focusing on nurturing promising biotech projects and fostering local and international collaborations.
These newly launched funds reflect Saudi Arabia’s strategic commitment to diversifying its economy through knowledge-based industries and building a world-class health innovation ecosystem under Vision 2030. By channeling significant capital into biotechnology, the Kingdom seeks to boost research and development, attract global expertise, and empower startups to develop breakthrough solutions in healthcare, pharmaceuticals, and advanced biotechnologies.
